Clinical characteristics of 45 patients with invasive pulmonary aspergillosis: retrospective analysis of 1711 lung cancer cases.

Abstract:

BACKGROUND:: Invasive aspergillosis (IA) is a common complication in patients with hematologic malignancies. Patients with solid tumors also are at risk for IA because they may develop neutropenia as a result of chemotherapy and radiotherapy. However, studies of IA in patients with solid tumors are rare. In this study, the risk factors and clinical characteristics of pulmonary infection and death mediated by invasive pulmonary aspergillosis (IPA) as complications in patients with lung cancer were determined. METHODS:: The authors conducted a retrospective analysis of the clinical notes from 45 patients who had IPA. RESULTS:: Among 1711 patients with lung cancer, 45 patients contracted pulmonary aspergillosis (2.63%). There were 10 cases of proven disease and 35 cases of probable disease. In univariate analysis, the main predisposing factors were clinical stage IV disease (P = .018), chemotherapy during the month preceding infection (P = .033), and corticosteroid use (> or =3 days; P = .038). In multivariate analysis, only clinical stage IV disease (P = .018) was associated with IPA. Furthermore, the mortality rate among lung cancer patients who had pulmonary aspergillosis was 51.1% (23 of 45 patients). Of the patients who died, corticosteroid therapy (P = .001) and grade 3/4 neutropenia (P = .013) were correlated statistically with pulmonary aspergillosis in patients with lung cancer. CONCLUSIONS:: In univariate analysis, the risk factors for IPA in lung cancer included chemotherapy and corticosteroid use in the month preceding infection and clinical stage IV disease. However, in multivariate analysis, only clinical stage IV disease was identified as a risk factor for IPA. Cancer 2009. (c) 2009 American Cancer Society.

journal_name

Cancer

journal_title

Cancer

authors

Yan X,Li M,Jiang M,Zou LQ,Luo F,Jiang Y

doi

10.1002/cncr.24559

subject

Has Abstract

pub_date

2009-11-01 00:00:00

pages

5018-25

issue

21

eissn

0008-543X

issn

1097-0142

journal_volume

115

pub_type

杂志文章

相关文献

CANCER文献大全
  • Clinical stage II non-small cell lung cancer treated with radiation therapy alone. The significance of clinically staged ipsilateral hilar adenopathy (N1 disease).

    abstract:BACKGROUND:The prognosis of patients with clinically staged hilar nodal involvement (Stage N1) or clinical Stage II non-small cell lung cancer (NSCLC, Stage T1-2N1M0) treated with radiation therapy (RT) alone is not well established. METHODS:Records of 758 patients with clinical Stage I-III NSCLC treated with RT were ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19921115)70:10<2410::aid-cncr282

    authors: Rosenthal SA,Curran WJ Jr,Herbert SH,Hughes EN,Sandler HM,Stafford PM,McKenna WG

    更新日期:1992-11-15 00:00:00

  • DNA flow cytometric analysis of serous ovarian tumors of low malignant potential.

    abstract:BACKGROUND:Ovarian serous tumors of low malignant potential (STLMP) occasionally progress; a small percentage of patients die of the tumor. There is no known way to predict which tumors will progress. METHODS:Forty STLMP were analyzed by DNA flow cytometry and compared with 26 serous carcinomas. RESULTS:Forty percent...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19930615)71:12<3947::aid-cncr282

    authors: Seidman JD,Norris HJ,Griffin JL,Hitchcock CL

    更新日期:1993-06-15 00:00:00

  • Concurrent vinblastine and radiation therapy in bladder cancer.

    abstract:BACKGROUND:Since mid-1987, 29 patients with invasive transitional cell carcinoma of the urinary bladder (T1-3 N0-X M0) were treated with concurrent radiation therapy (RT) (target dose [TD], 62-66 Gy) 1.8-2.0 Gy/day for 5 days a week with a break in the middle of treatment of 2-3 weeks and vinblastine weekly 2 mg/5-12 h...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19921215)70:12<2885::aid-cncr282

    authors: Kragelj B,Jereb B,Kragelj L,Stanonik M

    更新日期:1992-12-15 00:00:00

  • Phase I clinical trial and pharmacokinetics of carboplatin (NSC 241240) by single monthly 30-minute infusion.

    abstract::Carboplatin (diammine [1,1-cyclobutanedicarboxylate(2-)-O,o']platinum) is a second generation platinum coordination complex. It has a spectrum of activity that is similar to that of cisplatin and is less nephrotoxic and emetogenic in experimental animals. Fifty-two 30-minute infusions of carboplatin were given to 20 e...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19860115)57:2<222::aid-cncr28205

    authors: Koeller JM,Trump DL,Tutsch KD,Earhart RH,Davis TE,Tormey DC

    更新日期:1986-01-15 00:00:00

  • DTIC, CCNU, bleomycin and vincristine (BOLD) in metastatic melanoma.

    abstract::Treatment of 91 consecutive patients having metastatic, Stage IV melanoma who had not received any previous chemotherapy was begun between January 1977 and April 1978. The therapy included bleomycin (B) at 7.5 units subcutaneously in the first course and 15 units in subsequent courses on days 1 and 4; vincristine or O...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19801201)46:11<2346::aid-cncr282

    authors: Seigler HF,Lucas VS Jr,Pickett NJ,Huang AT

    更新日期:1980-12-01 00:00:00

  • Correlation between microsatellite instability and metachronous disease recurrence after endoscopic mucosal resection in patients with early stage gastric carcinoma.

    abstract:BACKGROUND:Since endoscopic treatment was first evaluated and established as a treatment for patients with early stage gastric carcinoma, metachronous disease recurrence at other sites in the stomach after endoscopic treatment has become a major problem. METHODS:A retrospective case-control study was conducted on 10 p...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Kawamura A,Adachi K,Ishihara S,Katsube T,Takashima T,Yuki M,Amano K,Fukuda R,Yamashita Y,Kinoshita Y

    更新日期:2001-01-15 00:00:00

  • Phase II study of doxorubicin plus ifosfamide/mesna in patients with advanced breast cancer.

    abstract::Four courses of ifosfamide with mesna given by intravenous infusions were combined with bolus doxorubicin in a phase II trial to treat patients with breast cancer. Ifosfamide can deplete intracellular glutathione levels and because doxorubicin resistance may be associated with elevated levels of intracellular glutathi...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19900601)65:11<2421::aid-cncr282

    authors: Millward MJ,Harris AL,Cantwell BM

    更新日期:1990-06-01 00:00:00

  • Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-hodgkin lymphoma.

    abstract:BACKGROUND:Central nervous system (CNS) recurrence is almost invariably fatal in patients with aggressive non-Hodgkin lymphoma (NHL). Although some protocols are intended to prevent CNS disease, the value of CNS prophylaxis in patients with aggressive NHL remains to be determined. METHODS:We retrospectively analyzed a...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.10699

    authors: Tomita N,Kodama F,Kanamori H,Motomura S,Ishigatsubo Y

    更新日期:2002-08-01 00:00:00

  • Oncocytic neoplasms of salivary glands: a report of fifteen cases including two malignant oncocytomas.

    abstract::Fifteen oncocytic (oxyphilic granular cell) neoplasms of the salivary glands collected from three large university medical centers are presented. The histologic and ultrastructural criteria that characterize oncocytes are presented and electron micrographs of two of our cases are discussed. Included in the series are ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197609)38:3<1306::aid-cncr282038

    authors: Gray SR,Cornog JL Jr,Seo IS

    更新日期:1976-09-01 00:00:00

  • Cost and risk benefit in the management of clinical stage II nonseminomatous testicular tumors.

    abstract:BACKGROUND:Two similarly effective treatment options exist for managing clinical low volume Stage II nonseminomatous germ cell testis tumors (NSGCT). Primary retroperitoneal lymph node dissection (RPLND) (with immediate adjuvant chemotherapy or chemotherapy at relapse) and primary chemotherapy have resulted in similar ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19950615)75:12<2897::aid-cncr282

    authors: Baniel J,Roth BJ,Foster RS,Donohue JP

    更新日期:1995-06-15 00:00:00

  • Cognitive-behavioral stress management improves stress-management skills and quality of life in men recovering from treatment of prostate carcinoma.

    abstract:BACKGROUND:The current study evaluated the efficacy of a 10-week, group-based, cognitive-behavioral stress management (CBSM) intervention relative to a half-day seminar in improving quality of life (QoL) among men who were treated for localized prostate carcinoma (PC) with either radical prostatectomy (RP) or radiation...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/cncr.11894

    authors: Penedo FJ,Dahn JR,Molton I,Gonzalez JS,Kinsinger D,Roos BA,Carver CS,Schneiderman N,Antoni MH

    更新日期:2004-01-01 00:00:00

  • Anatomic distribution of periprostatic adipose tissue: a mapping study of 100 radical prostatectomy specimens.

    abstract:BACKGROUND:Because the prostatic capsule is often indistinct, recognition of extraprostatic extension by carcinoma depends heavily on the identification of carcinoma cells in the periprostatic adipose tissue. However, the distribution of adipose tissue along the prostatic surfaces has not been studied extensively. MET...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.11231

    authors: Hong H,Koch MO,Foster RS,Bihrle R,Gardner TA,Fyffe J,Ulbright TM,Eble JN,Cheng L

    更新日期:2003-04-01 00:00:00

  • Treatment with bevacizumab and irinotecan for recurrent high-grade glial tumors.

    abstract:BACKGROUND:Response rates to second-line chemotherapy in recurrent high-grade glial tumors are low and new effective treatments are needed. The objective of this study was to evaluate response rates and tolerability of chemotherapy with bevacizumab and irinotecan in recurrent high-grade gliomas. METHODS:Twenty patient...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.23401

    authors: Bokstein F,Shpigel S,Blumenthal DT

    更新日期:2008-05-15 00:00:00

  • Progesterone therapy for endometrial carcinoma reduces cell proliferation but does not alter apoptosis.

    abstract:BACKGROUND:Although the anticancer effects of progesterone therapy for patients with endometrial carcinoma are widely acknowledged, a detailed assessment of the resultant morphologic alterations in tumor tissue kinetics has hitherto been lacking. METHODS:Biopsy and hysterectomy specimens of 14 endometrial carcinomas (...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19980701)83:1<111::aid-cnc

    authors: Saegusa M,Okayasu I

    更新日期:1998-07-01 00:00:00

  • Efficacy of follow-up bone scans in carcinoma of the prostate.

    abstract::Three hundred fifteen radioisotopic bone scans ranging from initial scan only to nine scans per patient, performed on 114 patients with adenocarcinoma of the prostate between 1979 and 1984, were reviewed. Seventeen patients had positive scans, ten on initial scan and seven at follow-up. Nine patients had bone pain at ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19880615)61:12<2453::aid-cncr282

    authors: Corrie D,Timmons JH,Bauman JM,Thompson IM

    更新日期:1988-06-15 00:00:00

  • Randomized controlled trials of treatments for hematologic malignancies: study characteristics and outcomes.

    abstract:BACKGROUND:Although randomized controlled trials (RCTs) require a great deal of time, money, and effort, the majority of them have resulted in failure to verify a priori hypotheses. Therefore, the intention in the current study was to clarify the differential elements of studies with 'positive' and 'negative' outcomes....

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.22776

    authors: Yanada M,Narimatsu H,Suzuki T,Matsuo K,Naoe T

    更新日期:2007-07-15 00:00:00

  • Disease control intervals in high-risk neuroblastoma.

    abstract:BACKGROUND:Current salvage therapy for recurrent high-risk neuroblastoma is rarely curative. Assessment of the effectiveness of new, primarily cytostatic agents requires the redefinition of study endpoints to reflect disease stabilization rather than tumor response or regression. The intervals of disease control in the...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.23507

    authors: Santana VM,Furman WL,McGregor LM,Billups CA

    更新日期:2008-06-15 00:00:00

  • Evolutive and prognostic aspects in gastric cancer. Analysis of 189 cases.

    abstract::The cases of 189 patients treated at the Surgery Service for gastric carcinoma from January 1960 to December 1978 and followed until April 1984 were reviewed in terms of evolutive behavior. Correlations between sex, age, duration of symptoms, site of tumors, lymph node metastases, stage of tumors, operability, resecta...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19870215)59:4<811::aid-cncr28205

    authors: Ziliotto A Jr,Kunzle JE,De Souza A,Colicchio-Filho O

    更新日期:1987-02-15 00:00:00

  • Malignant lymphoepithelial lesion of the parotid gland: poorly differentiated squamous cell carcinoma with lymphoid stroma.

    abstract::The case of a European patient with a malignant lymphoepithelial lesion of epithelial type is presented. This type of tumor has an exceptionally high incidence among Eskimos. To the authors' knowledge this is the first case reported with an ultrastructural study that demonstrates the squamous nature of the tumor cells...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19810715)48:2<289::aid-cncr28204

    authors: Redondo C,Garcia A,Vazquez F

    更新日期:1981-07-15 00:00:00

  • Validation of a tool for identifying women at high risk for hereditary breast cancer in population-based screening.

    abstract:BACKGROUND:Recent scientific advances provide the opportunity to identify women in the general population at increased breast cancer risk and to offer effective early detection and disease prevention interventions. METHODS:A pedigree assessment tool (PAT) was designed to identify women in primary care settings who are...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.22202

    authors: Hoskins KF,Zwaagstra A,Ranz M

    更新日期:2006-10-15 00:00:00

  • The chemotherapy of Hodgkin's disease: past experiences and future directions.

    abstract::From the standpoint of chemotherapy, the first progress in the treatment of Hodgkin's disease was the identification of the activity of nitrogen mustard in the 1940's. The initial antitumor effect of the drug created a great excitement. However, when all patients later relapsed, there was subsequent dejection and skep...

    journal_title:Cancer

    pub_type: 临床试验,历史文章,杂志文章,评审

    doi:10.1002/1097-0142(197808)42:2+<979::aid-cncr282042

    authors: DeVita VT Jr,Lewis BJ,Rozencweig M,Muggia FM

    更新日期:1978-08-01 00:00:00

  • Prognostic factors in male urethral cancer.

    abstract:BACKGROUND:Male urethral cancer is a rare neoplasm, with the published literature consisting of small single-institution retrospective series. As such, there is no objective analysis of prognostic factors and treatment outcome. The author sought to use the population-based Surveillance, Epidemiology, and End Results (S...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.25787

    authors: Rabbani F

    更新日期:2011-06-01 00:00:00

  • A critical analysis of prognostic factors in North American patients with human T-cell lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma: a multicenter clinicopathologic experience and new prognostic score.

    abstract:BACKGROUND:To define the clinicopathologic and prognostic features of patients with human T-cell lymphotropic virus type-1 (HTLV-1)-associated adult T-cell leukemia/lymphoma (ATLL) in North America, standard criteria were used to identify patients with ATLL. METHODS:Statistical analyses used included descriptive stati...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/cncr.25147

    authors: Phillips AA,Shapira I,Willim RD,Sanmugarajah J,Solomon WB,Horwitz SM,Savage DG,Bhagat G,Soff G,Zain JM,Alobeid B,Seshan VE,O'Connor OA

    更新日期:2010-07-15 00:00:00

  • Correlation of molecular human leukocyte antigen typing and outcome in high-risk melanoma patients receiving adjuvant interferon.

    abstract:BACKGROUND:Interferon is approved for adjuvant treatment of patients with stage IIB/III melanoma. The identification of predictive markers that would permit selection of patients would be beneficial. Specific human leukocyte antigen (HLA) class I and II antigens have previously shown an association with response to the...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.25211

    authors: Gogas H,Kirkwood JM,Falk CS,Dafni U,Sondak VK,Tsoutsos D,Stratigos A,Markopoulos C,Pectasides D,Spyropoulou-Vlachou M

    更新日期:2010-09-15 00:00:00

  • Use of adjuvant radiotherapy at hospitals with and without on-site radiation services.

    abstract:BACKGROUND:In many areas of health care, whether patients receive specific medical interventions often is influenced heavily by the local availability of resources for delivering those services. However, relations between resource availability and utilization are relatively unexplored in cancer care, including perioper...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.22458

    authors: Wong SL,Wei Y,Birkmeyer JD

    更新日期:2007-02-15 00:00:00

  • A survey of image-guided radiation therapy use in the United States.

    abstract:BACKGROUND:Image-guided radiation therapy (IGRT) is a novel array of in-room imaging modalities that are used for tumor localization and patient setup in radiation oncology. The prevalence of IGRT use among US radiation oncologists is unknown. METHODS:A random sample of 1600 radiation oncologists was surveyed by Inter...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.25129

    authors: Simpson DR,Lawson JD,Nath SK,Rose BS,Mundt AJ,Mell LK

    更新日期:2010-08-15 00:00:00

  • The sequential changes in DNA synthesis, glucose utilization, protein synthesis, and peripheral benzodiazepine receptor density in C6 brain tumors after chemotherapy to predict the response of tumors to chemotherapy.

    abstract:BACKGROUND:Monitoring therapy in patients with brain tumors is very difficult and unreliable. It has been shown that there is no good correlation between tumor sensitivity measured in vitro and in situ tumor response to therapies. METHODS:Sequential changes in tumor size, number of DNA synthesizing cells (labelling in...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19960315)77:6<1167::aid-cn

    authors: Takeda N,Diksic M,Yamamoto YL

    更新日期:1996-03-15 00:00:00

  • Applied cancer prevention in practice.

    abstract::In 1982, more than 125,000 cancer cases in the United States should be preventable. Every physician should advise all patients to eliminate all tobacco use, moderate alcohol use, avoid the use of drugs which are carcinogenic, minimize sun and x-ray exposure, maintain an ideal weight, and follow a "prudent" diet. Secon...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19830615)51:12+<2430::aid-cncr28

    authors: McKenna RJ

    更新日期:1983-06-15 00:00:00

  • An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation.

    abstract:BACKGROUND:There are large geographic gradients in mortality rates for a number of cancers in the U.S. (e.g., rates are approximately twice as high in the northeast compared with the southwest). Risk factors such as diet fail to explain this variation. Previous studies have demonstrated that the geographic distribution...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.10427

    authors: Grant WB

    更新日期:2002-03-15 00:00:00

  • A prospective postoperative evaluation of urinary tumor-associated antigens in sarcoma patients. Correlation with disease recurrence.

    abstract::Tumor-associated antigens (TAA) excreted into the urine of sarcoma patients can be detected by the complement-fixation assay. The authors prospectively measured TAA levels in the urine of 50 sarcoma patients postoperatively to determine whether reappearance of antigen in the urine would be predictive of disease recurr...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19840315)53:6<1306::aid-cncr2820

    authors: Huth JF,Gupta RK,Eilber FR,Morton DL

    更新日期:1984-03-15 00:00:00